Analysis

  • Around the World in 80 Days

    Drugs travel the world like never before. In the lead up to two co-located ViB conferences, Cold Chain Storage and Distribution USA and the 8th Annual Clinical Trials Supply East...

  • Antibodies: An Industry Almost Ready to Attack

    From arthritis to Crohn's disease, the applications for antibodies are plenty. In the lead up to the Americas Antibody Congress this month, Penny Jones tracked down industry expert Janiece Reichert...

  • Delivering a Safe H1N1 Vaccine

    Getting an H1N1 vaccine out the door fast is a priority for governments and pharmaceutical firms around the world. Making sure it is safe and that healthcare organisations have enough...

  • What Pharma Tanks Have in Store

    As the antibody sector becomes ever popular the need to increase capacity is growing. Dr Gareth Evans reports on how this is changing the dynamics in the field of pharmaceutical...

  • Controlling Clinical Contracting

    As a small firm betting high on one therapy, Solace Pharmaceuticals knows the importance of getting outsourcing right. Natalie Coomber talks to the company's executive director Kevin Pojasek about setting...

  • The Perfect Packaging Label

    Pharmaceutical companies have long focused on ploughing research into clinical trials. But with new readability guidelines just out, research is moving towards making sure the pharmaceutical package is perfect too....

  • Data Capture Changes the Face of Pharma

    From electronic data capture to taking a more psychological view, data collection in drug manufacturing is changing. Phil Taylor speaks to experts in the field about where some of the...

  • The Elusive Alzheimer’s Cure

    As people live longer, cases of Alzheimer's disease are getting more frequent. Mike Pearn investigates which pharmaceutical firms are willing to do battle with the high clinical trial costs.

  • A New Pharmaceutical World Order

    Global healthcare analysts IMS Healthcare recently forecast a new pharmaceutical market world order for 2013. This highlights the rapid rise of emerging countries, as Alex Hawkes investigates.

Close
Close
Close

Go Top